We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Luspatercept
Australian Public Assessment Report
Device/Product Name
Reblozyl
Active ingredients
Luspatercept
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-01706-1-6
Submission Type
New biological entity
Decision
Approved